X-136648287-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_StrongBP6_ModerateBP7BS1BS2
The NM_000074.3(CD40LG):c.39G>A(p.Ala13=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000317 in 1,200,025 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 15 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.000072 ( 0 hom., 0 hem., cov: 22)
Exomes 𝑓: 0.000028 ( 0 hom. 15 hem. )
Consequence
CD40LG
NM_000074.3 synonymous
NM_000074.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.811
Genes affected
CD40LG (HGNC:11935): (CD40 ligand) The protein encoded by this gene is expressed on the surface of T cells. It regulates B cell function by engaging CD40 on the B cell surface. A defect in this gene results in an inability to undergo immunoglobulin class switch and is associated with hyper-IgM syndrome. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant X-136648287-G-A is Benign according to our data. Variant chrX-136648287-G-A is described in ClinVar as [Benign]. Clinvar id is 1169681.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chrX-136648287-G-A is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=0.811 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.000072 (8/111092) while in subpopulation AMR AF= 0.000287 (3/10443). AF 95% confidence interval is 0.0000777. There are 0 homozygotes in gnomad4. There are 0 alleles in male gnomad4 subpopulation. Median coverage is 22. This position pass quality control queck.
BS2
High Hemizygotes in GnomAdExome4 at 15 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD40LG | NM_000074.3 | c.39G>A | p.Ala13= | synonymous_variant | 1/5 | ENST00000370629.7 | NP_000065.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD40LG | ENST00000370629.7 | c.39G>A | p.Ala13= | synonymous_variant | 1/5 | 1 | NM_000074.3 | ENSP00000359663 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000720 AC: 8AN: 111092Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33334
GnomAD3 genomes
AF:
AC:
8
AN:
111092
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
33334
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000437 AC: 8AN: 183221Hom.: 0 AF XY: 0.0000738 AC XY: 5AN XY: 67749
GnomAD3 exomes
AF:
AC:
8
AN:
183221
Hom.:
AF XY:
AC XY:
5
AN XY:
67749
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000275 AC: 30AN: 1088933Hom.: 0 Cov.: 28 AF XY: 0.0000423 AC XY: 15AN XY: 354619
GnomAD4 exome
AF:
AC:
30
AN:
1088933
Hom.:
Cov.:
28
AF XY:
AC XY:
15
AN XY:
354619
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000720 AC: 8AN: 111092Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33334
GnomAD4 genome
AF:
AC:
8
AN:
111092
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
33334
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Hyper-IgM syndrome type 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at